Delivery Order SPE2DB22D2206-SPE2DB25FFM88
Award Date
2/7/25
Potential Completion Date
3/3/25
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a medical product. The $17,802.18 firm fixed-price delivery order contract has a period of performance through February 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,141.87 firm fixed-price delivery order contract is for the supply of TECVAYLI 30 MG/3 ML VIAL 3ML, a specialty medication. The contract has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract, which has a firm fixed price of $35,736.42, is a delivery order with an ultimate completion date of September 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,283.74 firm fixed-price delivery order is for the supply of TECVAYLI 30 MG/3 ML VIAL 3ML, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $11,868.12, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TECVAYLI 153 MG/1.7 ML VIAL 1.7ML, a specialty pharmaceutical product, with a period of performance through February 4, 2025. This contract is a firm fixed-price delivery order and is not designated as a set-aside procurement. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product TECVAYLI 153 MG/1.7 ML VIAL 1.7ML. The contract, valued at $23,824.28, was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) on July 2, 2024, with a completion date of July 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $2,400.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of TECVAYLI 30 MG/3 ML VIAL 3ML medical product, with a performance period running through January 22, 2025. No set-aside designation was used for this contract. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,868.12, is for the delivery of the drug Tecvayli (153 mg/1.7 mL vial) to support military healthcare programs. The contract does not have a set-aside designation, indicating it was open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award to AmerisourceBergen Drug Corp is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $13,430.02, is for the delivery of a pharmaceutical product called TALVEY 40 MG/ML VIALML. The IDC has a ceiling value of $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is a Delivery Order valued at $26,371.20 for pharmaceutical vials. The contract has a completion date of May 17, 2023 and is a Firm Fixed Price agreement. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through November 2026 to provide a comprehensive range of medical commodities to support...